🇺🇸 FDA
Drug

bempedoic acid

Brand: NEXLIZET

approved

Quick answer

bempedoic acid (NEXLIZET), is a pharmaceutical active ingredient, associated with Esperion Therapeutics, with approved status in the US.

Key facts

INN
bempedoic acid
Brand
NEXLIZET
Route
ORAL
Formulation
TABLET
Originator
Esperion Therapeutics

Related patents

patent

US 12404227

Methods of making bempedoic acid and compositions of the same

Expires Mon Aug 28 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12398087

Methods of making bempedoic acid and compositions of the same

Expires Mon Aug 21 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12344578

Salt forms of bempedoic acid and methods for using the same

Expires Mon Jun 26 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11987548

Methods of making bempedoic acid and compositions of the same

Expires Mon May 16 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11926584

Methods of making bempedoic acid and compositions of the same

Expires Mon Mar 07 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11760714

Methods of making bempedoic acid and compositions of the same

Expires Mon Sep 14 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11613511

Methods of making bempedoic acid and compositions of the same

Expires Mon Mar 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11407705

Methods of making bempedoic acid and compositions of the same

Expires Mon Aug 04 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

Frequently asked questions

What is bempedoic acid?

bempedoic acid (NEXLIZET), is a pharmaceutical active ingredient, associated with Esperion Therapeutics, with approved status in the US.

What is the brand name for bempedoic acid?

NEXLIZET is a marketed brand name for bempedoic acid. Check FDA Drugs@FDA for the current US label holder.